|
Accession number;03A0196696
|
| Title;Evaluation of the Effect of HMG-CoA Reductase Inhibitors on the Hypercholesterolaemia Associated with Diabetes. |
| Author;
SEINO HIROAKI
(Otanishinochibyoin Tonyobyose)
YAMAGUCHI HIYOSHI
(Otanishinochibyoin Tonyobyose)
KIMURA MINAKO
(Otanishinochibyoin Tonyobyose)
YAMADA DAISHIRO
(Otanishinochibyoin Tonyobyose)
MIYAGUCHI SHUICHI
(Otanishinochibyoin Tonyobyose)
YAMAZAKI TOSHIRO
(Otanishinochibyoin Tonyobyose)
MISAKI ASAKO
(Otaatamibyoin)
KIKUCHI HIROAKI
(Otakinenbyoin)
|
Journal Title;Prog Med
|
Journal Code:F0664B
|
ISSN:0287-3648
|
|
VOL.23;NO.2;PAGE.727-735(2003)
|
| Figure&Table&Reference;FIG.6, TBL.9, REF.12 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;We investigated the effect of four of HMC-CoA reductase inhibitors on the lipid and lipoprotein cholesterol of the hypercholesterolaemia associated with diabetes. Moreover, we compared the rate of achievement to a management target value in the medical treatment effect by the HMG-CoA reductase. 1. Four HMG-CoA reductase inhibitors declined the TC and the LDL-C value significantly compared with before treatment. 2. Compared with other agents, the high rate of achievement was significantly intentionally obtainedby atorvastatin medication with TC and the LDL-C value. 3. Change of the glucose tolerance and the laboratory data before and behind treatment did not change with four HMG-CoA reductase inhibitors about a liver function obstacle, a kidney functional disorder, and rhabdomyolysis, but it was thought that safety was equivalent. (author abst.) |
|
|
|
Related Articles;
|
